Skip to main content
$14M deal to acquire Dx businesses from RPS Diagnostics finalized by Quidel

Quidel announced completion of an all-cash deal to buy RPS Diagnostics' InflammaDry and AdenoPlus diagnostic businesses for about $14 million. The businesses include rapid, lateral flow assays designed for the detection of infectious and inflammatory eye conditions.

Full Story: